Ramon Lacanilao, MD | |
30 Mallard Court, Beckley, WV 25801-3140 | |
(304) 255-0800 | |
(304) 255-1040 |
Full Name | Ramon Lacanilao |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 30 Mallard Court, Beckley, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124133228 | NPI | - | NPPES |
2160452 | Other | WV | UHC |
3792827 | Other | WV | CIGNA |
3810007472 | Medicaid | WV | |
1902692 | Other | WV | MTN ST BCBS |
10383200 | Medicaid | VA | |
7374822 | Other | WV | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 22204 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ramon Lacanilao, MD 30 Mallard Court, Beckley, WV 25801-3140 Ph: (304) 255-0800 | Ramon Lacanilao, MD 30 Mallard Court, Beckley, WV 25801-3140 Ph: (304) 255-0800 |
News Archive
Healthy but obese adolescents display abnormal responses to tests of blood vessel function, but after a short course of exercise their test results match those of lean youngsters, even though they remain heavy, according to a new study in the May 19, 2004 issue of the Journal of the American College of Cardiology.
In a new study, scientists from the Florida campus of The Scripps Research Institute have shed new light on these complex processes, showing that a particular protein plays a far more sophisticated role in neuron development than previously thought.
Hip resurfacing is often seen as a modern alternative to the more conventional total hip replacement, but new data from a study led by Rush University Medical Center suggest that a patient's age and gender are key to the operation's success.
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.
› Verified 8 days ago
Carlos Estanislao Lucero, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 403 Carriage Drive, Beckley, WV 25801 Phone: 304-255-7456 Fax: 304-255-5899 | |
Dr. Petaiah Mohan, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 194 Carriage Dr, Beckley, WV 25801 Phone: 304-255-6051 Fax: 304-255-6051 | |
Kim D Bennett, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 252 Rural Acres Dr, Beckley, WV 25801 Phone: 304-252-8551 Fax: 304-252-1790 | |
Dr. Michele Dawn Staton, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 S Kanawha St, Suite 110a, Beckley, WV 25801 Phone: 304-929-4646 Fax: 304-929-4649 | |
Dr. Malik Hamdan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 304-256-4100 Fax: 304-254-3016 | |
Dr. Saraswathi Mohan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 194 Carriage Dr, Beckley, WV 25801 Phone: 304-255-6051 Fax: 304-255-6051 |